About
Genedx Holdings Corp. (NASDAQ:WGS) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 13 2026
GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026
Mar 10 2026
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C
Mar 9 2026
GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership
Feb 23 2026
INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026
Feb 23 2026
GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026
Financials
Revenue
$427.54 M
Market Cap
$1.76 B
EPS
-0.73
Translate